Riley's miracle: three open-heart surgeries by age nine
Image: Facebook
Born prematurely at just 36 weeks in Cape Town, Riley entered the world facing incredible challenges with his heart. Within three hours of birth, his tiny hands and feet turned blue, leading doctors to diagnose him with congenital heart disease (CHD), a complex condition affecting his heart's structure.
From the very start, Riley showed remarkable strength. After being closely monitored in the neonatal ICU, he was transferred to Red Cross War Memorial Children's Hospital, where doctors diagnosed multiple serious heart defects including Double Outlet Right Ventricle (DORV), Pulmonary Atresia (PA), Ventricular Septal Defect (VSD), and a duct-dependent circulation on the Tetralogy spectrum.
At only 20 days old, Riley underwent his first heart surgery, where surgeons successfully inserted a right modified Blalock-Taussig (RMBT) shunt to improve oxygen flow in his blood. His journey was far from over; months later, Riley suffered a Tet Spell — a frightening episode where he turned deeply blue, struggled to breathe, and became limp.
'In the beginning, they told us two years max,' recalled his mother, Candice Swartland, 31, from Heideveld. 'That was after his first heart surgery. He was on life support countless times. The first two years were very tough, but he was so strong through it all.'
In September 2016, Riley had his second open-heart surgery, receiving a central shunt that further supported his fragile heart. His resilience never waned.
Fast forward to June 2025 — at just nine years old and now in Grade 4, Riley faced his sixth heart surgery and third open-heart operation at Red Cross War Memorial Children's Hospital. The eight-hour operation was among the most complex yet.
'This one was even riskier,' said Swartland. 'The odds are always 50/50. They had to cut veins from his leg to put in his chest. But he was ready. He told me, 'Mommy, nothing will happen, there's too much people praying for me.' He was actually excited — he just wanted it over and done with so that he could move on.'
Video Player is loading.
Play Video
Play
Unmute
Current Time
0:00
/
Duration
-:-
Loaded :
0%
Stream Type LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
0:00
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text Color White Black Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Transparent Semi-Transparent Opaque
Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps
Reset
restore all settings to the default values Done
Close Modal Dialog
End of dialog window.
Advertisement
Next
Stay
Close ✕
Ad loading
Riley is a superhero in his own right
Image: Supplied
Following surgery, Riley spent nine days in hospital recovery, including time in ICU where he was carefully monitored. Though he battled a chest infection and fluid around his lungs, his strength shone through. He was breathing independently, oxygen levels at 100%, sitting up and slowly eating again.
'He's okay now,' said Swartland. 'He just has water on the lungs, and we need to be back at the hospital on the 24th.'
The most recent operation is expected to be his last — for now. 'This one should hold for 8 to 10 years. By the time he needs another, he'll be an adult,' she explained.
Despite his condition, Riley lives a vibrant life. He's the eldest of two children, a proud big brother, and attends a mainstream school — something doctors once said would be unlikely.
'At his development clinic, they told us he'd be slow, that he wouldn't be able to attend a normal school,' said Swartland. 'Today, he's a top learner at a normal school.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
IOL News
2 days ago
- IOL News
Riley's miracle: three open-heart surgeries by age nine
Riley Falken is getting stronger by the day after his third open-heart surgery Image: Facebook Born prematurely at just 36 weeks in Cape Town, Riley entered the world facing incredible challenges with his heart. Within three hours of birth, his tiny hands and feet turned blue, leading doctors to diagnose him with congenital heart disease (CHD), a complex condition affecting his heart's structure. From the very start, Riley showed remarkable strength. After being closely monitored in the neonatal ICU, he was transferred to Red Cross War Memorial Children's Hospital, where doctors diagnosed multiple serious heart defects including Double Outlet Right Ventricle (DORV), Pulmonary Atresia (PA), Ventricular Septal Defect (VSD), and a duct-dependent circulation on the Tetralogy spectrum. At only 20 days old, Riley underwent his first heart surgery, where surgeons successfully inserted a right modified Blalock-Taussig (RMBT) shunt to improve oxygen flow in his blood. His journey was far from over; months later, Riley suffered a Tet Spell — a frightening episode where he turned deeply blue, struggled to breathe, and became limp. 'In the beginning, they told us two years max,' recalled his mother, Candice Swartland, 31, from Heideveld. 'That was after his first heart surgery. He was on life support countless times. The first two years were very tough, but he was so strong through it all.' In September 2016, Riley had his second open-heart surgery, receiving a central shunt that further supported his fragile heart. His resilience never waned. Fast forward to June 2025 — at just nine years old and now in Grade 4, Riley faced his sixth heart surgery and third open-heart operation at Red Cross War Memorial Children's Hospital. The eight-hour operation was among the most complex yet. 'This one was even riskier,' said Swartland. 'The odds are always 50/50. They had to cut veins from his leg to put in his chest. But he was ready. He told me, 'Mommy, nothing will happen, there's too much people praying for me.' He was actually excited — he just wanted it over and done with so that he could move on.' Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Ad loading Riley is a superhero in his own right Image: Supplied Following surgery, Riley spent nine days in hospital recovery, including time in ICU where he was carefully monitored. Though he battled a chest infection and fluid around his lungs, his strength shone through. He was breathing independently, oxygen levels at 100%, sitting up and slowly eating again. 'He's okay now,' said Swartland. 'He just has water on the lungs, and we need to be back at the hospital on the 24th.' The most recent operation is expected to be his last — for now. 'This one should hold for 8 to 10 years. By the time he needs another, he'll be an adult,' she explained. Despite his condition, Riley lives a vibrant life. He's the eldest of two children, a proud big brother, and attends a mainstream school — something doctors once said would be unlikely. 'At his development clinic, they told us he'd be slow, that he wouldn't be able to attend a normal school,' said Swartland. 'Today, he's a top learner at a normal school.'
The South African
2 days ago
- The South African
Comrades runner Moira Harding: 'I'm home and recovering well'
One of the most intense stories to emerge from this year's Comrades marathon was the story of runner Moira Harding, who went missing after completing the ultramarathon in Durban, before eventually being found more than 12 hours later in a critical condition. The 54-year-old was found in a hypothermic condition after battling nclement weather conditions throughout the night, and had to be urgently airlifted to hospital, where she spent the next couple of weeks undergoing intensive treatment. Towards the end of June, The South African revealed that Harding had made encouraging recovery progress and was set to be discharged from hospital. In an emotional personal message posted on a runners community group, she has shared a debt of gratitude to all those who assisted, supported and cared for her during 'one of the toughest moments' of her life. 'I would like to sincerely thank all those who supported me and prayed for me when I went missing at the end of the Comrades Marathon and was found 15 hours later, unconscious and unresponsive due to severe dehydration and extremely low sodium levels resulting in disorientation and delirium,' she shared. 'Your love and prayers carried me through one of the toughest moments of my life.' Harding went on to issue a 'heartfelt' thank you to all the responders, emergency services, medical staff, athletics club members, family, friends and others who had assisted in one way or another. 'Most importantly, all praise to my Lord and Saviour for protecting me throughout this ordeal, and for healing me,' she shared. 'Without Him this recovery would not have been possible. I am now home and recovering well, and I look forward to the journey ahead with renewed strength and gratitude.' Let us know by leaving a comment below, or send a WhatsApp to 060 011 0211. Subscribe to The South African website's newsletters and follow us on WhatsApp, Facebook, X and Bluesky for the latest news.
The Citizen
5 days ago
- The Citizen
Fact-checked: HIV/Aids breakthrough not a ‘cure', popular social media posts misrepresent the facts
While promising, a recent breakthrough in HIV research is not a 'cure' or a 'vaccine', as several posts claim on social media. The scientists involved say it could be many years before the technology is used as a cure. Users on Facebook, Instagram and X have shared the same 'BREAKING NEWS' message, claiming that 'A CURE FOR HIV/AIDS HAS JUST BEEN FOUND'. Africa Check found hundreds of these posts, the most popular of which have been viewed millions of times. The message is typically accompanied by a graphic which includes the text 'Researchers in Australia have just found a cure for HIV/Aids' and an image created using artificial intelligence tools, of a bottle labelled 'HIV Vaccine®'. Unfortunately, this claim is not true. The human immunodeficiency virus, or HIV, is a virus which attacks the immune system, the processes responsible for protecting the body from disease. If left untreated, it causes acquired immunodeficiency syndrome, or Aids. HIV can be treated with antiretroviral drugs, which prevent the virus from multiplying in a person's body. ARV treatment can lower the level of the virus in a person's body to the point that it is undetectable and cannot be transmitted to others. However, ARVs cannot eradicate the virus entirely. So what has prompted these 'breaking news' posts? In this case, there is a real scientific breakthrough behind these claims, but it has been described in a misleading way. Deliberately misleading headline and image shared alongside text copied from genuine news story These posts include paragraphs of text, describing the scientific breakthrough. They begin: A cure for HIV could be a step closer after researchers found a new way to force the virus out of hiding inside human cells. The virus's ability to conceal itself inside certain white blood cells has been one of the main challenges for scientists looking for a cure. It means there is a reservoir of the HIV in the body, capable of reactivation, that neither the immune system nor drugs can tackle. Now researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne, have demonstrated a way to make the virus visible, paving the way to fully clear it from the body. The text is identical to the first 12 paragraphs of a news article published by the UK's Guardian newspaper on 5 June 2025. None of the posts which Africa Check found clearly credited the Guardian as the source, nor did they include the entire article. The original article is headlined: 'Breakthrough in search for HIV cure leaves researchers 'overwhelmed'.' In the posts on social media this has been replaced, usually with a variation on 'Breaking News: A cure for HIV/Aids has just been found', sometimes misspelling Aids as 'Auds'. The Guardian article never refers to the research as a 'cure', but only as a promising step towards one. In sections of the article not included in the social media posts, researchers are quoted as being 'very hopeful' that the breakthrough could eventually be replicated in humans. But this could be a long way off. The Guardian notes: 'The path to using the technology as part of a cure for patients is long and would require successful tests in animals followed by safety trials in humans, likely to take years, before efficacy trials could even begin.' The Guardian links back to the original scientific paper, published in the journal Nature Communications. The paper also does not refer to its findings as a 'cure' for HIV. Although they don't represent a 'cure', the findings are a promising development in HIV research. Promising advancement in research, not HIV cure As already discussed, ARV medications can reduce the presence of HIV in a person's body, but not eradicate the virus entirely. The Nature Communications article covers research into a potential solution to this problem. In their paper and in comments to the Guardian, the University of Melbourne researchers describe a new method of delivering genetic material, known as mRNA, into certain kinds of white blood cells. HIV is able to infect these white blood cells, where it can essentially hide from the body's immune system and other forms of treatment. Being able to reach the virus inside those white blood cells opens up new opportunities to treat it. Vaccines against Covid-19 also made use of mRNA, which may be why the graphic accompanying these 'HIV cure' claims depicts an 'HIV vaccine'. (The image in the graphic is very similar to stock images that have existed since 2016.) The Nature Communications study did not use mRNA to vaccinate against HIV, but demonstrated that 'therapeutic mRNA', such as small pieces of mRNA designed to alert the immune system to the presence of the virus, could be delivered to these white blood cells. At time of writing, there is no cure for HIV/Aids. But besides this breakthrough, there have been other promising developments in HIV treatment. Real breakthroughs in HIV treatment In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it works, may prevent infection and therefore stop the spread of the disease. It was developed by US-based Vir Biotechnology. ARVs can be taken as pre-exposure prophylaxis, or PrEP, by people who are HIV negative but likely to be exposed to the virus. This can prevent transmission of HIV. However, PrEP must be taken frequently to ensure proper protection. Current South African PrEP guidelines involve taking one pill every day. Lenacapavir is an injectable drug which has been shown to reliably protect against HIV transmission for six months at a time, with some trials demonstrating protection for a full year. After successful trials, there are plans to begin use of the drug in countries such as South Africa, which has a particularly high burden of HIV. It has been approved for use in the US. Like other forms of PrEP, Lenacapavir is neither a 'cure' nor a 'vaccine', but can prevent HIV transmission. Because it is much longer lasting than other forms of PrEP, it may make it much easier to prevent transmission.
